Dynavax (DVAX) Misses Q3 EPS by 15c

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.90), $0.15 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $162 thousand versus the consensus estimate of $2.44 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• William Blair Starts Yesway Inc (YSWY) at Outperform
• Here Group posts FY2026 results with $88M revenue, goodwill write-down